Table 2.
Exploring the associations between serum cotinine levels and cardiovascular disease risk
| Exposure | Non-adjusted OR (95%CI) P-value |
Adjust I OR (95%CI) P-value |
Adjust II OR (95%CI) P-value |
|---|---|---|---|
| Log Cotinine | 1.05 (1.01, 1.10) 0.0273 | 1.21 (1.14, 1.27) < 0.0001 | 1.25 (1.18, 1.33) < 0.0001 |
| Log Cotinine (quartile) | |||
| Q1 | Ref | Ref | Ref |
| Q2 | 0.81 (0.63, 1.04) 0.0979 | 0.97 (0.74, 1.28) 0.8393 | 0.94 (0.69, 1.27) 0.6733 |
| Q3 | 0.89 (0.71, 1.10) 0.2854 | 1.25 (0.99, 1.60) 0.0654 | 1.16 (0.89, 1.52) 0.2683 |
| Q4 | 1.06 (0.86, 1.31) 0.5698 | 2.07 (1.63, 2.64) < 0.0001 | 2.33 (1.77, 3.07) < 0.0001 |
| P for trend | 0.6010 | < 0.0001 | < 0.0001 |
Non-adjusted model adjust for: None
Adjust I model adjust for: Sex; Age; Race
Adjust II model adjust for: Sex; Age; Race; SBP; DBP; BMI; Waist; HDL-c; TG; LDL-c; TC; HbA1c; FPG; A; ALT; AST; BUN; CR; TB; UA; Alcohol; HTN; DM; CKD; Anti-platelet; β-blockers; ACEI/ARB; Statin; Diuretic; Anticoagulant